Vaccination reduces the viral load and the risk of transmission of Jembrana disease virus in Bali cattle

Virology

Volumn 386, Issue 2, 2009, Pages 317-324

  Ditcham, William G F ^a   Lewis, Joshua R ^a   Dobson, Robert J ^a   Hartaningsih, Nining ^b   Wilcox, Graham E ^a   Desport, Moira ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b Disease Investigation Centre   (Indonesia)

Author keywords

Bovine lentivirus; Jembrana disease virus; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; VIRUS RNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CATTLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; IMMUNE FUNCTION TEST; JEMBRANA DISEASE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; VACCINATION; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; FEMALE; IMMUNOGLOBULIN G; LENTIVIRUS INFECTIONS; LENTIVIRUSES, BOVINE; LINEAR MODELS; RNA, VIRAL; VACCINATION; VIRAL LOAD; VIRAL VACCINES;

ANIMALIA; BOS; BOVINE LENTIVIRUSES; JEMBRANA DISEASE VIRUS;

EID: 62949094995     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.02.008     Document Type: Article

References (39)

1. Ambrose Z., Thompson J., Larsen K., Kuller L., Panicali D.L., Clements J.D., Agy M., Montefiori D.C., Hu S.L., and Bosch M.L. Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV(89.6). Virology 308 1 (2003) 178-190
2. Brandin E., Thorstensson R., Bonhoeffer S., and Albert J. Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy. J. Virol. 80 19 (2006) 9861-9864
3. Chadwick B.J., Coelen R.J., Wilcox G.E., Sammels L.M., and Kertayadnya G. Nucleotide sequence analysis of Jembrana disease virus: a bovine lentivirus associated with an acute disease syndrome. J. Gen. Virol. 76 Pt 7 (1995) 1637-1650
4. Chen P., Liu Z.Q., and Wood C. Use of TrpE fusion protein to identify antigenic domains within the BIV envelope protein. J. Virol. Methods 47 3 (1994) 331-343
5. Coles G.C., Bauer C., Borgsteede F.H., Geerts S., Klei T.R., Taylor M.A., and Waller P.J. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) methods for the detection of anthelmintic resistance in nematodes of veterinary importance. Vet. Parasitol. 44 1-2 (1992) 35-44
6. Cook R.F., Cook S.J., Berger S.L., Leroux C., Ghabrial N.N., Gantz M., Bolin P.S., Mousel M.R., Montelaro R.C., and Issel C.J. Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides. Virology 313 2 (2003) 588-603
7. Desport M., Stewart M.E., Sheridan C.A., Ditcham W.G., Setiyaningsih S., Tenaya W.M., Hartaningsih N., and Wilcox G.E. Recombinant Jembrana disease virus gag proteins identify several different antigenic domains but do not facilitate serological differentiation of JDV and nonpathogenic bovine lentiviruses. J. Virol. Methods 124 1-2 (2005) 135-142
8. Desport M., Stewart M.E., Mikosza A.S., Sheridan C.A., Peterson S.E., Chavand O., Hartaningsih N., and Wilcox G.E. Sequence analysis of Jembrana disease virus strains reveals a genetically stable lentivirus. Virus Res. 126 1-2 (2007) 233-244
9. Desport M., Ditcham W.G.F., Lewis J.R., McNab T.J., Stewart M.E., Hartaningsih N., and Wilcox G.E. Analysis of Jembrana disease virus replication dynamics in vivo reveals strain variation and atypical responses to infection. Virology 386 2 (2009) 310-316
10. Dharma D.M., Budiantono A., Campbell R.S., and Ladds P.W. Studies on experimental Jembrana disease in Bali cattle. III. Pathology. J. Comp. Pathol. 105 4 (1991) 397-414
11. Diehl L.J., Mathiason-Dubard C.K., O'Neil L.L., and Hoover E.A. Plasma viral RNA load predicts disease progressionin accelerated feline immunodeficiency virus infection. J. Virol. 70 4 (1996) 2503-2507
12. Fauci A.S., Schnittman S.M., Poli G., Koenig S., and Pantaleo G. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 114 8 (1991) 678-693
13. Foil L.D., Adams W.V., McManus J.M., and Issel C.J. Bloodmeal residues on mouthparts of Tabanus fuscicostatus (Diptera: Tabanidae) and the potential for mechanical transmission of pathogens. J. Med. Entomol. 24 6 (1987) 613-616
14. Hartaningsih N., Wilcox G.E., Dharma D.M., and Soetrisno M. Distribution of Jembrana disease in cattle in Indonesia. Vet. Microbiol. 38 1-2 (1993) 23-29
15. Hartaningsih N., Wilcox G.E., Kertayadnya G., and Astawa M. Antibody response to Jembrana disease virus in Bali cattle. Vet. Microbiol. 39 1-2 (1994) 15-23
16. Hartaningsih N., Dharma D.M., Soeharsono S., and Wilcox G.E. The induction of a protective immunity against Jembrana disease in cattle by vaccination with inactivated tissue-derived virus antigens. Vet. Immunol. Immunopathol. 78 2 (2001) 163-176
17. Hawkins J.A., Adams Jr. W.V., Wilson B.H., Issel C.J., and Roth E.E. Transmission of equine infectious anemia virus by Tabanus fuscicostatus. J. Am. Vet. Med. Assoc. 168 1 (1976) 63-64
18. Hosie M.J., Dunsford T., Klein D., Willett B.J., Cannon C., Osborne R., Macdonald J., Spibey N., Mackay N., Jarrett O., and Neil J.C. Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J. Virol. 74 20 (2000) 9403-9411
19. Issel C.J., and Foil L.D. Studies on equine infectious anemia virus transmission by insects. J. Am. Vet. Med. Assoc. 184 3 (1984) 293-297
20. Issel C.J., Horohov D.W., Lea D.F., Adams Jr. W.V., Hagius S.D., McManus J.M., Allison A.C., and Montelaro R.C. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66 6 (1992) 3398-3408
21. Kertayadnya G., Wilcox G.E., Soeharsono S., Hartaningsih N., Coelen R.J., Cook R.D., Collins M.E., and Brownlie J. Characteristics of a retrovirus associated with Jembrana disease in Bali cattle. J. Gen. Virol. 74 Pt 9 (1993) 1765-1778
22. Mascola J.R., Lewis M.G., Stiegler G., Harris D., VanCott T.C., Hayes D., Louder M.K., Brown C.R., Sapan C.V., Frankel S.S., Lu Y., Robb M.L., Katinger H., and Birx D.L. Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73 5 (1999) 4009-4018
23. Mazzetti P., Giannecchini S., Del Mauro D., Matteucci D., Portincasa P., Merico A., Chezzi C., and Bendinelli M. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine. J. Virol. 73 1 (1999) 1-10
24. Muraguri G.R., Kiara H.K., and McHardy N. Treatment of East Coast fever: a comparison of parvaquone and buparvaquone. Vet. Parasitol. 87 1 (1999) 25-37
25. Poli G., and Fauci A.S. Cytokine modulation of HIV expression. Semin. Immunol. 5 3 (1993) 165-173
26. Raabe M.L., Issel C.J., and Montelaro R.C. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus. Virology 259 2 (1999) 416-427
27. Richardson J., Broche S., Baud S., Leste-Lasserre T., Femenia F., Levy D., Moraillon A., Pancino G., and Sonigo P. Lymphoid activation: a confounding factor in AIDS vaccine development?. J. Gen. Virol. 83 Pt 10 (2002) 2515-2521
28. Russo P., Vitu C., Fontaine J.J., and Vignoni M. [Caprine arthritis-encephalitis: trial of an adjuvant vaccine preparation. I. Clinical and virological study]. Comp. Immunol. Microbiol. Infect. Dis. 16 2 (1993) 131-136
29. Sattentau Q.J. Neutralization of HIV-1 by antibody. Curr. Opin. Immunol. 8 4 (1996) 540-545
30. Scobie L., Venables C., Hughes K., Dawson M., and Jarrett O. The antibody response of cattle infected with bovine immunodeficiency virus to peptides of the viral transmembrane protein. J. Gen. Virol. 80 Pt 1 (1999) 237-243
31. Setiyaningsih S., Desport M., Stewart M.E., Hartaningsih N., and Wilcox G.E. Sequence analysis of mRNA transcripts encoding Jembrana disease virus Tat-1 in vivo. Virus Res. 132 1-2 (2008) 220-225
32. Silvera P., Richardson M.W., Greenhouse J., Yalley-Ogunro J., Shaw N., Mirchandani J., Khalili K., Zagury J.F., Lewis M.G., and Rappaport J. Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J. Virol. 76 8 (2002) 3800-3809
33. Soeharsono S., Hartaningsih N., Soetrisno M., Kertayadnya G., and Wilcox G.E. Studies of experimental Jembrana disease in Bali cattle. I. Transmission and persistence of the infectious agent in ruminants and pigs, and resistance of recovered cattle to re-infection. J. Comp. Pathol. 103 1 (1990) 49-59
34. Soeharsono S., Wilcox G.E., Putra A.A., Hartaningsih N., Sulistyana K., and Tenaya M. The transmission of Jembrana disease, a lentivirus disease of Bos javanicus cattle. Epidemiol. Infect. 115 2 (1995) 367-374
35. Stewart M., Desport M., Hartaningsih N., and Wilcox G. TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection. J. Clin. Microbiol. 43 11 (2005) 5574-5580
36. Waisman A., Ruiz P.J., Hirschberg D.L., Gelman A., Oksenberg J.R., Brocke S., Mor F., Cohen I.R., and Steinman L. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2 8 (1996) 899-905
37. Wareing S., Hartaningsih N., Wilcox G.E., and Penhale W.J. Evidence for immunosuppression associated with Jembrana disease virus infection of cattle. Vet. Microbiol. 68 1-2 (1999) 179-185
38. Wilcox G. Jembrana disease. Aust. Vet. J. 7 (1997) 492-493
39. Yamamoto J.K., Hohdatsu T., Olmsted R.A., Pu R., Louie H., Zochlinski H.A., Acevedo V., Johnson H.M., Soulds G.A., and Gardner M.B. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67 1 (1993) 601-605